Information
for investors

hero background image

Financial
information

arrow-down

2Q / 2023

Coming soon…

3Q / 2023

Coming soon…

4Q / 2023

Coming soon…

Some of the information or materials made available on this website may contain forward-looking statements. Statements including words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to assumptions, risks and uncertainties that could cause actual events or actual future results to differ materially from the expectations set forth in the forward-looking statements.

SEC Filings

arrow-down
arrow-down
Date Filling type Description
Jan 6, 2023 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d) arrow
Jan 3, 2023 6-K Press Release for Closing of Business Combination arrow
Dec 30, 2022 Form - CERT Nasdaq's certification of the registrant's application on Form 8-A 12(b) arrow
Dec 30, 2022 8-A12B Registration of securities [Section 12(b)] arrow
Dec 5, 2022 EFFECT Notice of Effectiveness arrow
Dec 5, 2022 424B3 Prospectus arrow
Dec 2, 2022 425 Investor Presentation Filing arrow
Dec 1, 2022 F-4/A Registration of securities, foreign private issuers, business combinations-amendment arrow
Nov 21, 2022 F-4/A Registration of securities, foreign private issuers, business combinations-amendment arrow
Oct 28, 2022 425 Investor Presentation Filing arrow
Oct 18, 2022 425 Prospectuses and communications, business combinations arrow
Oct 17, 2022 F-4 Registration of securities, foreign private issuers, business combinations arrow
Sep 27, 2022 DRS/A Draft Registration Statement - amendment arrow
Aug 12, 2022 DRS Draft Registration Statement arrow
Jun 14, 2022 8-K Business Combination Agreement arrow

Let's build together
the future of food.

Send us an email ir@moolecscience.com

Book a meeting with our IR people Download Media Kit